The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction.

Abstract

Stimulator of interferon genes (STING) is an important adaptor in cytosolic DNA-sensing pathways. A recent study found that the deletion of STING ameliorated cisplatin-induced acute kidney injury (AKI), suggesting that STING could serve as a potential target for AKI therapy. Up to now, a series of small-molecule STING inhibitors/antagonists have been identified. However, none of the research was performed to explore the role of human STING inhibitors in AKI. Here, we investigated the effect of a newly generated covalent antagonist, H151, which targets both human and murine STING, in cisplatin-induced AKI. We found that H151 treatment significantly ameliorated cisplatin-induced kidney injury as shown by the improvement of renal function, kidney morphology, and renal inflammation. In addition, tubular cell apoptosis and increased renal tubular injury marker neutrophil gelatinase-associated lipocalin induced by cisplatin were also effectively attenuated in H151-treated mice. Moreover, the mitochondrial injury caused by cisplatin was also reversed as evidenced by improved mitochondrial morphology, restored mitochondrial DNA content, and reversed mitochondrial gene expression. Finally, we observed enhanced mitochondrial DNA levels in the plasma of patients receiving platinum-based chemotherapy compared with healthy controls, which could potentially activate STING signaling. Taken together, these findings suggested that H151 could be a potential therapeutic agent for treating AKI possibly through inhibiting STING-mediated inflammation and mitochondrial injury.NEW & NOTEWORTHY Although various stimulator of interferon genes (STING) inhibitors have been identified, no research was performed to investigate the role of human STING inhibitors in AKI. Here, we evaluated the effect of H151 targeting both human and murine STING on cisplatin-induced AKI and observed a protection against renal injury possibly through ameliorating inflammation and mitochondrial dysfunction.

• Authors: Wei Gong, Lingling Lu, Yu Zhou, Jiaye Liu, Haoyang Ma, Lvhan Fu, Songming Huang, Yue Zhang, Aihua Zhang, Zhanjun Jia
• Journal: American journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 320 Issue 4 Pg. F608-F616 (04 01 2021) ISSN: 1522-1466 [Electronic] United States
• PMID: 33615891 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Lipocalin-2
• Cisplatin

Topics

• Acute Kidney Injury (drug therapy, metabolism)
• Animals
• Apoptosis (drug effects)
• Cisplatin (pharmacology)
• Inflammation (metabolism)
• Kidney (drug effects, metabolism)
• Lipocalin-2 (drug effects, metabolism)
• Mice
• Mitochondria (drug effects, metabolism)
• Nephritis (metabolism)
• Signal Transduction (drug effects)